Keros halts blood pressure treatment trial on safety issues
The company was testing its therapy, cibotercept, in patients with pulmonary arterial hypertension (PAH) - a rare disease ...
Things You Probably Don't Know About Viagra (Like What It Was Originally Used For)
Whether you’re a senior in high school or a senior-living resident, you’ve likely heard of Viagra (sildenafil) — the original ...
Retired Worcester firefighter Mark Stomski dies; injured in line of duty in 2008
Retired Worcester firefighter Mark Stomski died on Sunday due to complications from injuries he sustained before his 2008 ...
Latin Times on MSN3h
UnitedHealth Is Price Gouging Cancer Patients by Overcharging 'Thousands of Percent' for Live-Saving Meds, Pocketing Extra Billions: Feds
The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...
Keros Therapeutics price target lowered to $32 from $33 at BofA
BofA analyst Jason Zemansky lowered the firm’s price target on Keros Therapeutics (KROS) to $32 from $33 and keeps a Buy rating on the shares.
Johnson & Johnson (JNJ) Gets a Hold from Barclays
Barclays analyst Matt Miksic maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) today and set a price target of $160.00.
Rep. Josh Gottheimer Purchases Shares of Johnson & Johnson (NYSE:JNJ)
Representative Josh Gottheimer (D-New Jersey) recently bought shares of Johnson & Johnson (NYSE:JNJ). In a filing disclosed on January 14th, the Representative disclosed that they had bought between ...
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive on the streets of New York. Luigi Mangione ended up receiving an ...
Scotiabank maintained Keros Therapeutics at Sector Outperform
Scotiabank (TSX:BNS) analysts revised the price target for Keros Therapeutics (NASDAQ:KROS) shares, reducing it to $41 from ...
How to keep track of your fitness without the scale
If you’re short on time, Stoner recommends the three-minute step test as another alternative that offers a score of aerobic ...
Keros stock price target cut on study termination
Oppenheimer adjusted its price target on Keros Therapeutics (NASDAQ:KROS) shares, reducing it significantly to $23.00 from ...
ClimateConnections1h
Indirect death toll from the L.A. fires may end up in the thousands
The toxic smoke from the fires, combined with disruption to the economy, health care system, and mental health may lead to thousands of deaths over the coming years.